Skip to content
AnalystLens

CME GROUP INC. 8-K Report, Corporate Update (Mar 2, 2022)

Reports
Other Events·Exhibits & Filings
Filing Date
Filed March 2, 2022
Period End
March 1, 2022
Security
CME
In the record · 2016–202610-K1110-Q328-K119

CME filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 119 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Nov ’18Nov ’18
  2. Material agreement8-K · Apr ’21Apr ’21
  3. Leadership change8-K · Sep ’26Sep ’26

01—Abstract

Summary

Summary of the 8-K filed March 2, 2022. Cited figures are marked; the original filing is the authoritative source.

CME Group Inc. (CME) announced on March 1, 2022, its entry into an Underwriting Agreement for a public offering of $750 milliona in 2.650% Notes due 2032.

This offering signifies the company's intention to raise substantial capital through debt issuance, with the notes maturing in 2032. The agreement includes standard provisions such as representations, warranties, covenants, and indemnification clauses between CME Group and the underwriters, represented by Barclays Capital Inc. and BofA Securities, Inc. This debt issuance is a key event for investors as it impacts the company's capital structure and future interest expenses.

The proceeds from this offering are expected to be used for general corporate purposes, although specific use cases are not detailed in this filing. Investors should monitor how CME Group utilizes these funds and how the increased debt load affects its financial leverage and profitability.

02—Key points

Key Highlights

  1. CME Group Inc. is issuing $750,000,000 aggregate principal amount of 2.650% Notes due 2032.
  2. The notes are being sold in an underwritten public offering.
  3. The Underwriting Agreement was entered into on March 1, 2022.
  4. Barclays Capital Inc. and BofA Securities, Inc. are acting as representatives of the underwriters.
  5. The agreement contains customary representations, warranties, covenants, and indemnification provisions.
  6. The filing does not specify the exact use of proceeds but implies general corporate purposes.

03—Questions

Frequently Asked Questions

  1. What is the primary purpose of this 8-K filing?

    The primary purpose of this 8-K filing is to announce CME Group Inc.'s entry into an Underwriting Agreement for a public offering of $750 million in 2.650% Notes due 2032.

  2. What are the key terms of the new notes being issued?

    The new notes will have a principal amount of $750,000,000, a coupon rate of 2.650%, and will mature in 2032.

  3. Who are the underwriters for this offering?

    Barclays Capital Inc. and BofA Securities, Inc. are acting as the representatives of the underwriters in this public offering.

  4. What does the Underwriting Agreement typically cover?

    The Underwriting Agreement typically covers customary representations, warranties, and covenants made by the issuer (CME Group) and the underwriters. It also includes provisions for indemnification against certain liabilities and contribution mechanisms.

04—Continue

← View all 8-K filings